Nutra Pharma Announces Licensing and Marketing Agreement for Pet Pain-Away(TM)
CORAL SPRINGS, FL--(Marketwired - Nov 9, 2016) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for …